Bills · HR 6255
IN COMMITTEE· 119TH CONGRESS
House BillHR 6255Health
Affordable Insulin Now Act
INTRO NOV 21· LAST ACTION NOV 21
READING
10MIN
COSPONSORS
9
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill addresses the rising cost of insulin, which has been a major financial burden for many people with diabetes. If passed, it would provide financial relief by limiting how much individuals pay out-of-pocket for insulin each month, making this life-saving medication more accessible and predictable in cost.
Without this bill, many individuals could continue to face high deductibles and uncapped costs for insulin, potentially leading them to ration their medication or forgo it entirely due to expense, which can have severe health consequences. It aims to reduce the stress and financial strain associated with managing a chronic condition.
KEY PROVISIONS
4AI-extractedPROVISION 01
Caps out-of-pocket cost for a 30-day supply of selected insulin products at the lesser of $35 or 25% of the negotiated price.
This directly limits the monthly financial burden for insulin users with private insurance.
PROVISION 02
Prohibits health plans and insurers from applying a deductible to selected insulin products.
This ensures individuals do not have to pay a large sum upfront before the cost cap applies.
PROVISION 03
Specifies that payments made under the cost-sharing cap must count towards any deductible or out-of-pocket maximum under the plan.
This ensures the capped payments contribute to reaching annual limits on healthcare spending, protecting consumers from excessive overall costs.
PROVISION 04
Defines "selected insulin products" as at least one of each dosage form and type, chosen by the plan or insurer, and clarifies that plans are not required to cover or cap costs for out-of-network or non-selected insulin.
This gives flexibility to insurers in product selection but ensures a basic level of capped options while allowing higher costs for out-of-network or non-preferred options.
SPONSORSHIP
1 + 9
D· Minnesota
YRS IN OFFICE
7
BILLS LED
21
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 9 REP 0 IND 0
ACTION TIMELINE
2 EVENTSNOV 21
Introduced in House
NOV 21
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
BILL INFO
TypeHouse Bill
NumberHR 6255
Congress119th
StatusIn Committee
IntroducedNov 21, 2025
Last actionNov 21, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · WAYS AND MEANS COMMITTEE · INTRODUCED NOV 21, 2025
House BillHR 6255Health
Affordable Insulin Now Act
INTRODUCED NOV 21, 2025· LAST ACTION NOV 21, 2025
PASSAGE CHANCES
—%
READING
10 min
COSPONSORS
9
COMPLEXITY
Moderate
